rt-111
Generic: ustekinumab biosimilar·Code: RT-111
rt-111: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Rani Therapeutics Holdings, Inc. (RANI) | Phase 1 |
Get deeper analysis on rt-111
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis